NASDAQ: SNCE - Science 37 Holdings, Inc.

Yield per half year: 0%
Sector: Healthcare

Share chart Science 37 Holdings, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About

Science 37 Holdings, Inc. engages in patient-centric clinical trial activities in North Carolina. Its platform enables modern and digital approaches to clinical research, including the patient and trial investigators, nurses, coordinators, and sponsors, standardize evidence generation, and harmonize data.

more details
The company's platform also provides specialized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, and connected devices for orchestrating clinical trials; and extensive configuration to support virtually any phase of clinical study and therapeutic area. In addition, the company licenses its proprietary hosted technology platform to various life science institutions. It serves large and mid-sized pharmaceutical companies, contract research organizations, academic institutions, and biotech companies. Science 37 Holdings, Inc. was founded in 2014 and is based in Research Triangle Park, North Carolina.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2020-11-20
ISIN US8086441081
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.science37.com
Цена ао 5.75
Change price per day: 0% (5.75)
Change price per week: 0% (5.75)
Change price per month: 0% (5.75)
Change price per 3 month: 0% (5.75)
Change price per half year: 0% (5.75)
Change price per year: +7.68% (5.34)
Change price per 3 year: -52.6% (12.13)
Change price per 5 year: 0% (5.75)
Change price per 10 year: 0% (5.75)
Change price per year to date: 0% (5.75)
All parameters

Underestimation

Title Value Grade
P/S 0.6789 10
P/BV 0.489 10
P/E 0 0
EV/EBITDA 0.4243 10
Total: 6.25

Efficiency

Title Value Grade
ROA, % -26.33 0
ROE, % -46.57 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.0093 10
Total: 9.8

Growth impulse

Title Value Grade
Yield Revenue, % 154.27 10
Yield Ebitda, % 426.07 10
Yield EPS, % 11478.95 10
Total: 10
More

Institutions Volume Share, %
Redmile Group, LLC 990412 0.83
Kent Lake Capital, LLC 278560 0.23
Glynn Capital Management Llc 176992 0.15
Russell Investments Group, Ltd. 169696 0.14
Vanguard Group Inc 160367 0.13
Alphabet Inc. 160364 0.13
MIC Capital Management UK LLP 117295 0.1
Alyeska Investment Group, L.P. 88319 0.07
Citadel Advisors Llc 67631 0.06
Samsara BioCapital, LLC 45000 0.04



Head Job title Payment Year of birth
Mr. David Coman CEO & Director 796.13k 1970 (55 years)
Ms. Christine A. Pellizzari J.D. Chief Legal & Human Resources Officer and Secretary 521.58k 1968 (57 years)
Ms. Darcy Forman Chief Delivery Officer 550.58k 1976 (49 years)
Mr. Mike Zaranek Chief Financial Officer N/A 1971 (54 years)
Irena Lambridis VP and Head of Quality Assurance & Compliance N/A
Ms. Margie Gimbel Kooman Vice President of Marketing & Communications N/A
Mr. Drew Bustos Chief Strategy & Marketing Officer N/A
Mr. Jonathan Cotliar M.D. Chief Medical Officer 486.6k 1972 (53 years)
Mr. Michael Shipton Chief Commercial Officer N/A 1972 (53 years)
Mr. Tyler Van Horn VP of Corporate Strategy & Chief of Staff N/A

Address: United States, Research Triangle Park. NC, 800 Park Offices Drive - open in Google maps, open in Yandex maps
Website: https://www.science37.com